206 related articles for article (PubMed ID: 8267669)
1. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
[TBL] [Abstract][Full Text] [Related]
3. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
[TBL] [Abstract][Full Text] [Related]
4. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Rehn D; Unkauf M; Klein P; Jost V; Lücker PW
Arzneimittelforschung; 1996 May; 46(5):483-7. PubMed ID: 8737631
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness and safety of hydroxyethyl-rutosides in the local treatment of symptoms of venous insufficiency during air travel].
Gouny AM; Horovitz D; Gouny P; Sauvage E; Nussaume O
J Mal Vasc; 1999 Jun; 24(3):214-20. PubMed ID: 10467532
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the therapeutic equivalence of different galenical preparations of O-(beta-hydroxyethyl)-rutosides following multiple dose peroral administration.
Rehn D; Brunnauer H; Diebschlag W; Lehmacher W
Arzneimittelforschung; 1996 May; 46(5):488-92. PubMed ID: 8737632
[TBL] [Abstract][Full Text] [Related]
7. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
8. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
10. O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study.
Belcaro G; Rosaria Cesarone M; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():7S-13S. PubMed ID: 18287162
[TBL] [Abstract][Full Text] [Related]
11. Parenteral troxerutin and carbazochrome combination in the treatment of post-hemorrhoidectomy status: a randomized, double-blind, placebo-controlled, phase IV study.
Basile M; Gidaro S; Pacella M; Biffignandi PM; Gidaro GS
Curr Med Res Opin; 2001; 17(4):256-61. PubMed ID: 11922398
[TBL] [Abstract][Full Text] [Related]
12. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
[TBL] [Abstract][Full Text] [Related]
13. O-(beta-hydroxyethyl)-rutosides (Paroven; Venoruton): new studies, improved safety, and novel cardiovascular applications.
Cesarone MR; Belcaro G; Grossi MG
Angiology; 2008; 59 Suppl 1():5S-6S. PubMed ID: 18287161
[No Abstract] [Full Text] [Related]
14. [Efficacy of O-(beta-hydroxyethyl)-rutosides in the treatment of venous leg ulcers].
Stegmann W; Hubner K; Deichmann B; Muller B
Phlebologie; 1987; 40(1):149-56. PubMed ID: 3554278
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study.
Rabe E; Stücker M; Esperester A; Schäfer E; Ottillinger B
Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):540-7. PubMed ID: 21239190
[TBL] [Abstract][Full Text] [Related]
16. Clinical improvement in chronic venous insufficiency signs and symptoms with Venoruton® (HR): an 8-month, open-registry, cost-efficacy study.
Cesarone MR; Belcaro G; Ippolito E; Pellegrini L; Ledda A; Luzzi R; Ricci A; Dugall M; Bavera P; Hosoi M; Stuard S; Corsi M
Panminerva Med; 2010 Jun; 52(2 Suppl 1):43-8. PubMed ID: 20657534
[TBL] [Abstract][Full Text] [Related]
17. [The behavior of blood clotting and its inhibitors under long term treatment with 5,6-benzo-alpha-pyrone (coumarin). Double blind study].
Köstering H; Bandura B; Merten HA; Wieding JU
Arzneimittelforschung; 1985; 35(8):1303-6. PubMed ID: 3907641
[TBL] [Abstract][Full Text] [Related]
18. An open-label, randomised multicentre study comparing the efficacy and safety of CYCLO 3 FORT versus hydroxyethyl rutoside in chronic venous lymphatic insufficiency.
Beltramino R; Penenory A; Buceta AM
Int Angiol; 1999 Dec; 18(4):337-42. PubMed ID: 10811525
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis and hemorheology in chronic venous insufficiency: a double blind study of troxerutin efficiency.
Boisseau MR; Taccoen A; Garreau C; Vergnes C; Roudaut MF; Garreau-Gomez B
J Cardiovasc Surg (Torino); 1995 Aug; 36(4):369-74. PubMed ID: 7593149
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of a coumarin-/troxerutin-combination (SB-LOT) in patients with chronic venous insufficiency: a double blind placebo-controlled randomised study.
Vanscheidt W; Rabe E; Naser-Hijazi B; Ramelet AA; Partsch H; Diehm C; Schultz-Ehrenburg U; Spengel F; Wirsching M; Götz V; Schnitker J; Henneicke-von Zepelin HH
Vasa; 2002 Aug; 31(3):185-90. PubMed ID: 12236023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
